Dendreon (DNDN_) target cut at Goldman. Shares of DNDN now seen reaching $14. Company needs to improve execution with Provenge. Buy rating. http://www.thestreet.com/_yahoo/story/11276608/1/analysts-actions-msft-dndn-rimm-vz-nflx.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA